Comparative Safety and Effectiveness of Apixaban Dosing in Patients With Atrial Fibrillation and Severe CKD

被引：0
|
作者：
Xu, Yunwen [1 ]
Chang, Alex R. [2 ]
Inker, Lesley A. [3 ]
McAdams-DeMarco, Mara [4 ]
Grams, Morgan [1 ,4 ]
Shin, Jung-Im [1 ]
机构：
[1] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[2] Geisinger Hlth, Danville, PA USA
[3] Tufts Med CTR, Boston, MA USA
[4] NYU, Grossman Sch Med & Langone Hlth, New York, NY USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO896
引用
收藏
页码：305 / 305
页数：1
相关论文
共 50 条
  • [1] Comparative effectiveness and safety of apixaban and rivaroxaban in cirrhosis and atrial fibrillation
    Simon, Tracey G.
    Zhang, Yichi
    Mastrorilli, Julianna
    Cervone, Alexander
    Lin, Kueiyu Joshua
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 56 - 57
  • [2] Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
    Fu, Edouard L.
    Desai, Rishi J.
    Paik, Julie M.
    Kim, Dae Hyun
    Zhang, Yichi
    Mastrorilli, Julianna M.
    Cervone, Alexander
    Lin, Kueiyu Joshua
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (03) : 293 - 305.e1
  • [3] Effectiveness and Safety of Apixaban Versus Rivaroxaban for Patients With Atrial Fibrillation
    不详
    ANNALS OF INTERNAL MEDICINE, 2020, 172 (07) : 463 - 473
  • [4] Initial apixaban dosing in patients with atrial fibrillation
    Buchholz, Alexander
    Ueberham, Laura
    Gorczynska, Kaja
    Dinov, Borislav
    Hilbert, Sebastian
    Dagres, Nikolaos
    Husser, Daniela
    Hindricks, Gerhard
    Bollmann, Andreas
    CLINICAL CARDIOLOGY, 2018, 41 (05) : 671 - 676
  • [5] EFFECTIVENESS AND SAFETY OF APIXABAN, RIVAROXABAN AND WARFARIN IN PATIENTS WITH ADVANCED CKD AND ATRIAL FIBRILLATION: A NATIONWIDE US COHORT STUDY
    Fu, Edouard
    Desai, Rishi
    Paik, Julie
    Kim, Dae
    Zhang, Yichi
    Mastrorilli, Julianna
    Cervone, Alexander
    Lin, Joshua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I130 - I132
  • [6] Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
    Andersson, Niklas W.
    Svanstrom, Henrik
    Lund, Marie
    Pasternak, Bjorn
    Melbye, Mads
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 268 : 113 - 119
  • [7] Comparative Effectiveness of Rivaroxaban, Apixaban, and Warfarin in Atrial Fibrillation Patients With Polypharmacy
    Mentias, Amgad
    Heller, Eric
    Vaughan Sarrazin, Mary
    STROKE, 2020, 51 (07) : 2076 - 2086
  • [8] Associations of Apixaban Dose With Safety and Effectiveness Outcomes in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
    Xu, Yunwen
    Chang, Alexander R.
    Inker, Lesley A.
    McAdams-DeMarco, Mara
    Grams, Morgan E.
    Shin, Jung-Im
    CIRCULATION, 2023, 148 (19) : 1445 - 1454
  • [9] Comparative Effectiveness and Safety of Apixaban, Rivaroxaban, and Warfarin in Patients With Cirrhosis and Atrial Fibrillation: A Nationwide Cohort Study
    Simon, Tracey G.
    Singer, Daniel E.
    Zhang, Yichi
    Mastrorilli, Julianna M.
    Cervone, Alexander
    DiCesare, Elyse
    Lin, Kueiyu Joshua
    ANNALS OF INTERNAL MEDICINE, 2024, 177 (08)
  • [10] Safety outcomes of apixaban in patients with nonvalvular atrial fibrillation and severe renal impairment
    Jones, Maura J.
    Eudaley, Sarah T.
    Moye, Robert A.
    Hodge, Terry A.
    Nesbit, Ross M.
    Franks, Andrea S.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (02) : 330 - 336
12345